Involvement of the first transmembrane segment of human alpha(2)-adrenoceptors in the subtype-selective binding of chlorpromazine, spiperone and spiroxatrine




Laurila JMM, Wissel G, Xhaard H, Ruuskanen JO, Johnson MS, Scheinin M

PublisherWILEY-BLACKWELL

2011

British Journal of Pharmacology

BRITISH JOURNAL OF PHARMACOLOGY

BRIT J PHARMACOL

5

164

5

1558

1572

15

0007-1188

DOIhttps://doi.org/10.1111/j.1476-5381.2011.01520.x



TM1 is involved in determining the low affinity of some antagonist ligands at the human alpha(2A)-adrenoceptor. The exact mechanism is not known, but the position of TM1 at a large distance from the binding pocket indicates that TM1 does not participate in specific side-chain interactions with amino acids within the binding pocket of the receptor or with ligands bound therein. Instead, molecular models suggest that TM1 has indirect conformational effects related to the charge distribution or overall shape of the binding pocket.



Last updated on 2024-26-11 at 18:30